Crinetics Pharmaceuticals annual operating margin
2016
2017
2018
2019
2020
2023
2024
2025
Crinetics Pharmaceuticals Operating Margin Growth & History (CRNX)
Crinetics Pharmaceuticals's operating margin was −6,714.77% for fiscal 2025.
View full Crinetics Pharmaceuticals company overviewCrinetics Pharmaceuticals annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −6,714.77% | +25898.70 pp |
| 2024 | 2024-12-31 | −32,613.47% | −27066.30 pp |
| 2023 | 2023-12-31 | −5,547.17% | — |
| 2020 | 2020-12-31 | −105,567.61% | −101055.28 pp |
| 2019 | 2019-12-31 | −4,512.32% | −3329.87 pp |
| 2018 | 2018-12-31 | −1,182.45% | −736.15 pp |
| 2017 | 2017-12-31 | −446.31% | +579.84 pp |
| 2016 | 2016-12-31 | −1,026.15% | — |
Crinetics Pharmaceuticals quarterly operating margin
Q2.17
Q3.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q3.19
Q4.19
Q1.20
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −527.35% | +11995.64 pp |
| Q1 2026 | 2026-03-31 | −1,307.79% | +29552.32 pp |
| Q4 2025 | 2025-12-31 | −2,169.55% | — |
| Q3 2025 | 2025-09-30 | −99,710.49% | — |
| Q2 2025 | 2025-06-30 | −12,522.99% | +8224.63 pp |
| Q1 2025 | 2025-03-31 | −30,860.11% | −19371.20 pp |
| Q2 2024 | 2024-06-30 | −20,747.62% | −15383.75 pp |
| Q1 2024 | 2024-03-31 | −11,488.91% | −9698.01 pp |
| Q3 2023 | 2023-09-30 | −17,045.38% | −7557.60 pp |
| Q2 2023 | 2023-06-30 | −5,363.87% | +4441.37 pp |
| Q1 2023 | 2023-03-31 | −1,790.89% | −710.50 pp |
| Q3 2022 | 2022-09-30 | −9,487.77% | — |
| Q2 2022 | 2022-06-30 | −9,805.24% | — |
| Q1 2022 | 2022-03-31 | −1,080.39% | — |
| Q1 2020 | 2020-03-31 | −25,045.07% | −22308.29 pp |
| Q4 2019 | 2019-12-31 | −4,739.56% | −3532.01 pp |
| Q3 2019 | 2019-09-30 | −3,015.64% | −1543.02 pp |
| Q1 2019 | 2019-03-31 | −2,736.78% | −1486.56 pp |
| Q4 2018 | 2018-12-31 | −1,207.55% | — |
| Q3 2018 | 2018-09-30 | −1,472.63% | −1101.69 pp |
| Q2 2018 | 2018-06-30 | −864.99% | −667.52 pp |
| Q1 2018 | 2018-03-31 | −1,250.23% | — |
| Q3 2017 | 2017-09-30 | −370.94% | — |
| Q2 2017 | 2017-06-30 | −197.48% | — |
Crinetics Pharmaceuticals operating margin trends
Over the last five fiscal years, Crinetics Pharmaceuticals's operating margin increased from −105,567.61% to −6,714.77%, a change of +98852.83 percentage points. The latest reported quarter, Q2 2026, shows −527.35%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Crinetics Pharmaceuticals source filings ↗